Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.
Product Specifications
CAS Number
2095668-10-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.43
Molecular Formula
C21H21FN6O2
Notes
Research use only, not for human use.
Receptor
Ferroptosis
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2396232 100 µL
Factor B Rabbit Polyclonal Antibody (PerCP-Cy5.5)
Sign In for Pricing
View Details FAB10521P-100 100 Tests
Human EN-RAGE Phycoerythrin MAb (Clone 161205)
Sign In for Pricing
View Details